Free Trial

Scholar Rock (SRRK) Stock Price, News & Analysis

Scholar Rock logo
$43.21 0.00 (0.00%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$43.39 +0.18 (+0.41%)
As of 04:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Scholar Rock Stock (NASDAQ:SRRK)

Advanced

Key Stats

Today's Range
$42.76
▼
$44.16
50-Day Range
$39.60
▼
$57.42
52-Week Range
$34.25
▼
$61.76
Volume
623,508 shs
Average Volume
1.59 million shs
Market Capitalization
$5.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.67
Consensus Rating
Moderate Buy

Company Overview

Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-β) superfamily, which plays roles in processes including muscle development and immune regulation.

The company’s lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients’ motor function.

Scholar Rock was founded in 2012. Its research and development programs have also included medicines targeting TGF-β signaling in cancer, reflecting the company’s broader approach of developing therapies that modulate the activation of growth factors.

AI Generated. May Contain Errors.

Scholar Rock Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

SRRK MarketRank™: 
3.326727440875 of 5 stars

Scholar Rock scored higher than 67% of companies evaluated by MarketBeat, and ranked 265th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Scholar Rock has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 3 strong buy ratings, 10 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside Potential

    Scholar Rock has a consensus price target of $67.67, representing about 56.6% upside from its current price of $43.21.

  • Amount of Analyst Coverage

    Scholar Rock has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Scholar Rock's stock forecast and price target.
  • Earnings Growth

    Earnings for Scholar Rock are expected to grow in the coming year, from ($3.04) to ($2.80) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Scholar Rock is -12.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Scholar Rock is -12.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Scholar Rock has a P/B Ratio of 17.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    21.49% of the float of Scholar Rock has been sold short.
  • Short Interest Ratio / Days to Cover

    Scholar Rock has a short interest ratio ("days to cover") of 13.58, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Scholar Rock has recently increased by 5.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Scholar Rock does not currently pay a dividend.

  • Dividend Growth

    Scholar Rock does not have a long track record of dividend growth.

  • News Sentiment

    Scholar Rock has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 33 news articles for Scholar Rock this week, compared to 5 articles on an average week.
  • Search Interest

    Only 2 people have searched for SRRK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Scholar Rock to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $12,000,582.00 in company stock, which represents 0.2276% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Scholar Rock insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,000,582.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.30% of the stock of Scholar Rock is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    91.08% of the stock of Scholar Rock is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Scholar Rock's insider trading history.
Receive SRRK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scholar Rock and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SRRK Stock News Headlines

Scholar Rock (NASDAQ:SRRK) Stock Rating Lowered by Wolfe Research
HC Wainwright Boosts Earnings Estimates for Scholar Rock
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
HC Wainwright Predicts Scholar Rock Q1 Earnings
Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript
See More Headlines

SRRK Stock Analysis - Frequently Asked Questions

Scholar Rock's stock was trading at $44.05 at the beginning of 2026. Since then, SRRK shares have decreased by 1.9% and is now trading at $43.21.

Scholar Rock Holding Corporation (NASDAQ:SRRK) posted its quarterly earnings data on Tuesday, November, 10th. The company reported ($0.81) EPS for the quarter, topping analysts' consensus estimates of ($0.85) by $0.04. The business earned $570 thousand during the quarter, compared to analyst estimates of $304 thousand.
Read the conference call transcript
.

Scholar Rock (SRRK) raised $75 million in an initial public offering (IPO) on Thursday, May 24th 2018. The company issued 5,360,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Scholar Rock's top institutional shareholders include State Street Corp (3.59%), Voya Investment Management LLC (0.77%), GW&K Investment Management LLC (0.30%) and Pictet Asset Management Holding SA (0.30%). Insiders that own company stock include Public Equities LP Invus, Srinivas Akkaraju, David Hallal, Akshay Vaishnaw, Keith Woods, Keith Woods, Vikas Sinha, Jay T Backstrom, Junlin Ho, Caryn Parlavecchio, Jing L Marantz, Kristina Burow, Edward H Myles, Mo Qatanani, Tracey Sacco, Michael Gilman, Katie Peng, Jeffrey S Flier and Joshua Reed.
View institutional ownership trends
.

Shares of SRRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scholar Rock investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Rocket Lab (RKLB), Micron Technology (MU), Eli Lilly and Company (LLY), Vertiv (VRT) and Nebius Group (NBIS).

Company Calendar

Last Earnings
11/10/2026
Today
11/15/2026
UBS Global Biopharma Conference 2026
11/16/2026
Jefferies Global Healthcare Conference
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SRRK
CIK
1727196
Employees
289
Year Founded
2012

Price Target and Rating

High Price Target
$84.00
Low Price Target
$42.00
Potential Upside/Downside
+56.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
17 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$377.94 million
Net Margins
N/A
Pretax Margin
-72,563.16%
Return on Equity
-175.27%
Return on Assets
-86.66%

Debt

Debt-to-Equity Ratio
1.16
Current Ratio
5.41
Quick Ratio
5.40

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.41 per share
Price / Book
17.93

Miscellaneous

Outstanding Shares
122,000,000
Free Float
109,438,000
Market Cap
$5.27 billion
Optionable
Optionable
Beta
0.78

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:SRRK) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners